Autobio Diagnostics Co Ltd (603658) — Cash Flow-to-Debt Ratio
Autobio Diagnostics Co Ltd (603658) has a Cash Flow-to-Debt Ratio of 0.15x as of September 2025, meaning its operating cash flow of CN¥435.24 Million could theoretically repay 0% of its total liabilities (CN¥2.88 Billion) in one year. See Autobio Diagnostics Co Ltd (603658) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Autobio Diagnostics Co Ltd Cash Flow-to-Debt Ratio (2011–2024)
Historical debt coverage capacity for Autobio Diagnostics Co Ltd across 14 annual periods. Also explore 603658 shareholders equity momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Autobio Diagnostics Co Ltd (2011–2024)
Year-by-year debt coverage analysis for Autobio Diagnostics Co Ltd. For market capitalisation and broader financial context, see 603658 company net worth.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.41x | CN¥1.31 Billion | CN¥3.18 Billion | ▼ -19.2% |
| 2023 | 0.51x | CN¥1.47 Billion | CN¥2.89 Billion | ▼ -16.4% |
| 2022 | 0.61x | CN¥1.56 Billion | CN¥2.56 Billion | ▼ -23.8% |
| 2021 | 0.80x | CN¥1.46 Billion | CN¥1.83 Billion | ▲ +24.6% |
| 2020 | 0.64x | CN¥994.71 Million | CN¥1.55 Billion | ▲ +23.4% |
| 2019 | 0.52x | CN¥842.89 Million | CN¥1.62 Billion | ▼ -45.1% |
| 2018 | 0.95x | CN¥653.73 Million | CN¥690.69 Million | ▼ -2.2% |
| 2017 | 0.97x | CN¥481.73 Million | CN¥497.85 Million | ▼ -58.9% |
| 2016 | 2.36x | CN¥415.82 Million | CN¥176.52 Million | ▲ +73.3% |
| 2015 | 1.36x | CN¥308.63 Million | CN¥227.01 Million | ▼ -20.1% |
| 2014 | 1.70x | CN¥256.93 Million | CN¥151.08 Million | ▲ +15.3% |
| 2013 | 1.47x | CN¥103.22 Million | CN¥70.00 Million | ▼ -1.3% |
| 2012 | 1.49x | CN¥69.32 Million | CN¥46.41 Million | ▲ +16.2% |
| 2011 | 1.29x | CN¥50.59 Million | CN¥39.36 Million | — |